BAX vs STE
BAX: Baxter International is a leading medical technology company delivering critical life-sustaining therapies for patients with complex medical conditions in hospitals and at home. STE: A premier provider of essential infection prevention, sterilization, and procedural care solutions for healthcare and life sciences organizations worldwide.
Side-by-side fundamentals
| Metric | BAX | STE | Edge |
|---|---|---|---|
| Price as of 2026-08-06 close | $27.01 | $231.78 | |
| Market cap as of 2026-08-08 | $14.0B | $22.6B | |
| P/E as of 2026-08-08 | n/a | 29.53 | |
| PEG as of 2026-08-08 | -0.02 | 1.18 | BAX lower |
| Net margin as of 2026-08-08 | -9.3% | +13.2% | STE higher |
| Gross margin as of 2026-08-08 | +30.7% | +44.3% | STE higher |
| Operating margin as of 2026-08-08 | -2.3% | +18.5% | STE higher |
| ROE as of 2026-08-08 | -16.6% | +11.1% | STE higher |
| ROA as of 2026-08-08 | -5.3% | +7.4% | STE higher |
| Debt / equity as of 2026-08-08 | 1.52 | 0.27 | STE lower |
| Revenue growth (YoY) as of 2026-08-08 | +5.4% | +8.7% | STE higher |
| Revenue CAGR (3y) SEC XBRL | +3.8% | +9.4% | STE higher |
| Dividend yield as of 2026-08-08 | +0.1% | +1.2% | STE higher |
| Dividend streak (yrs) SEC XBRL | 1 | 5 | STE higher |
| Beta as of 2026-08-08 | 0.66 | 0.92 | |
| 1-year return as of 2026-08-06 close | +20.0% | +4.8% | BAX higher |
Fundamentals: market data, as of 2026-08-08. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-06.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.